Interim results from PAZOREAL: A non-interventional study to assess effectiveness and safety of pazopanib and everolimus in the changing mRCC treatment landscape
Bedke J, Welslau M, Boegemann M, Schostak M, Hering-Schubert C, Petzoldt A, Wolf T, Schleicher J, Doehn C, Gruellich C, Gruenwald V, Steiner T, Ehness R, Klein D, Medinger T, Goebell P (2017)
Publication Type: Conference contribution
Publication year: 2017
Journal
Book Volume: 28
Authors with CRIS profile
Involved external institutions
Westfälische Wilhelms-Universität (WWU) Münster
Germany (DE)
iOMEDICO AG
Germany (DE)
Universitätsklinikum Jena
Germany (DE)
Novartis AG
Switzerland (CH)
HELIOS Kliniken
Germany (DE)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Germany (DE)
Katharinenhospital Stuttgart
Germany (DE)
Universitätsklinikum Heidelberg
Germany (DE)
Universitätsklinikum Magdeburg A.ö.R.
Germany (DE)
Urologikum Lübeck
Germany (DE)
Universitätsklinikum Tübingen
Germany (DE)
Germany (DE)
iOMEDICO AG
Germany (DE)
Universitätsklinikum Jena
Germany (DE)
Novartis AG
Switzerland (CH)
HELIOS Kliniken
Germany (DE)
Medizinische Hochschule Hannover (MHH) / Hannover Medical School
Germany (DE)
Katharinenhospital Stuttgart
Germany (DE)
Universitätsklinikum Heidelberg
Germany (DE)
Universitätsklinikum Magdeburg A.ö.R.
Germany (DE)
Urologikum Lübeck
Germany (DE)
Universitätsklinikum Tübingen
Germany (DE)
How to cite
APA:
Bedke, J., Welslau, M., Boegemann, M., Schostak, M., Hering-Schubert, C., Petzoldt, A.,... Goebell, P. (2017). Interim results from PAZOREAL: A non-interventional study to assess effectiveness and safety of pazopanib and everolimus in the changing mRCC treatment landscape.
MLA:
Bedke, J., et al. "Interim results from PAZOREAL: A non-interventional study to assess effectiveness and safety of pazopanib and everolimus in the changing mRCC treatment landscape." 2017.
BibTeX: Download